EPIPEN

the U.S. doesn’t regulate medicine prices, so drugmakers can charge as much as they want.

Sen. Claire McCaskill, D-Missouri, said in a statement Thursday, “I’m tired of playing whack-a-mole with these pharmaceutical companies that are grabbing obscene profits while they have a monopoly.”

Now many members of Congress from both parties, along with Democratic presidential candidate Hillary Clinton, are demanding answers from Mylan.

Sen. Joe Manchin, D-W. Va. — Mylan head Heather Bresch’s father, wasn’t so harsh.

“I look forward to reviewing (Mylan’s) response in detail and working with my colleagues and all interested parties to lower the price of prescription drugs,” he said in a statement.

Carolyn Janis, 35, of Middlefield, Connecticut, is waiting to fill a new EpiPen prescription for her 2-year-old son, Noah, that’s needed before he starts daycare next month. He’s allergic to eggs and all nuts.

She paid $175 under an old insurance plan but now has a high-deductible plan and she’s already exhausted her health savings account. Janis said she’d explore the patient assistance Mylan is offering.

“I am anxious about how much it’s going to cost,” she said.